Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of anaesthetized rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 366, Issue 6, 2002, Pages 570-577

  Matsumoto, Machiko ^a   Kojima, Taku ^a   Togashi, Hiroko ^a   Mori, Kiyoshi ^a   Ohashi, Satoshi ^a   Ueno, Ken Ichi ^a   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT1A receptors; 5 HT4 receptors; 5 HT7 receptors; CA1 field; CA3 field; Synaptic transmission

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2A [4 (4 PHENYL 1,2,3,6 TETRAHYDROPYRIDYL)BUTYL] 2A,3,4,5 TETRAHYDROBENZO[C,D]INDOL 2(1H) ONE; 3 [2 (4 METHYLPIPERIDIN 1 YL)ETHYL]PYRROLIDINE 1 SULFONYLPHENOL; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 4 AMINO 5 CHLORO N [(HEXAHYDRO 1H PYRROLIZIN 1 YL)METHYL] 2 METHOXYBENZAMIDE; DR 4004; FLUVOXAMINE MALEATE; PYRROLIDINE DERIVATIVE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN 7 RECEPTOR ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TANDOSPIRONE; UNCLASSIFIED DRUG; ANESTHETIC AGENT; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; NONHUMAN; RAT; SPIKE WAVE; SYNAPTIC TRANSMISSION; ACTION POTENTIAL; ANIMAL; COMPARATIVE STUDY; PHYSIOLOGY; WISTAR RAT;

ACTION POTENTIALS; ANESTHETICS; ANIMALS; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 0036443684     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0634-y     Document Type: Article

References (39)

1. 7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 294:672-679
2. Barbaccia ML, Brunello N, Chuang DM, Costa E (1983) Serotonin-elicited amplification of adenylate cyclase activity in hippocampal membranes from adult rat. J Neurochem 40:1671-1679
3. Beck SG, Choi KC, List TJ (1992) Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 263:350-359
4. 4 splice variant. J Neurochem 74:478-489
5. 4 receptor activation in the rat hippocampus. Naunyn Schmiedeberg's Arch Pharmacol 355:14-19
6. 4 receptor activation. Naunyn-Schmiedeberg's Arch Pharmacol 363:491-493
7. 1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther 265:16-23
8. Colino A, Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328:73-77
9. Figgitt DP, McClellan KJ (2000) Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs 60:925-954
10. 4 receptor subtype. J Med Chem 35:1486-1489
11. 7 receptor in rat brain. Br J Pharmacol 117:657-666
12. Hagan JJ, Price GW, JeffreyP, Deeks N J, Stean T, Piper D, Smith MI, Upton N, Medhurst AD, Middlemiss D N, Riley G J, Lovell PJ, Bromidge SM, Thomas DR (2000) Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 130:539-548
13. Heidmann DE, Szot P, Kohen R, Hamblin MW (1998) Function and distribution of three rat 5-hydroxytryptamine 7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37:1921-1632
14. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
15. 7 receptor. J Med Chem 42:533-535
16. Kishimoto K, Koyama S, Akaike N (2000) Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala. Eur J Pharmacol 407:257-265
17. Li XB, Inoue T, Hashimoto S, Koyama T (2001) Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol 425:43-50
18. Majeed NH, Lason W, Przewlocka B, Przewlocki R (1985) Differential modulation of the beta-endorphin and dynorphin systems by serotonergic stimulation in the rat. Neuropeptides 5:563-566
19. Markstein R, Matsumoto M, Kohler C, Togashi H, Yoshioka M, Hoyer D (1999) Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 359:454-459
20. 4 receptors in cholinergic function associated with cognitive processes: Behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther 296:676-682
21. 1A receptors in guinea pig dentate gyrus. Brain Res 761:105-112
22. McLean S, Rothman RB, Jacobson AE, Rice KC, Herkenham M (1987) Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol 255:497-510
23. 1A agonist tandospirone, on hippocampal long-term potentiation in vivo. Pharmacol Biochem Behav 69:367-372
24. 1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J Neurophysiol 71:2161-2164
25. Olivier B, Gommans J, van der Gugten J, Bouwknecht JA, Herremans AH, Patty T, Hijzen TH (1999) Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures. Pharmacol Biochem Behav 64:213-220
26. Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230
27. 1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 127:1751-1764
28. 4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology 33:551-557
29. Schreiber R, Melson C, De Vry J (1998) The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin re-uptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology 135:383-391
30. Shenker A, Maayani S, Weinstein H, Green JP (1985) Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone. Eur J Pharmacol 109:427-429
31. 1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: Single-unit study in unanesthetized, unrestrained rats. J Pharmacol Exp Ther 288:843-848
32. Vida I, Frotsher M (2000) A hippocampal interneuron associated with the mossy fiber system. Neurobiology 97:1275-1280
33. Villacres EC, Wong ST, Chavkin C, Storm DR (1998) Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci 18:3186-3194
34. Vogt KE, Nicoll R A (1999) Glutamate and gamma-aminobutyric acid mediate a heterosynaptic depression at mossy fiber synapses in the hippocampus. Proc Natl Acad Sci USA 96:1118-1122
35. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347-352
36. Weisskopf MG, Zalusky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362:423-427
37. Weisskopf MG, Castillo PE, Zalusky RA, Nicoll RA (1994) Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265:1878-1882
38. Xu L, Anwyl R, Rowan MJ (1997) Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 387:497-500
39. Yoshioka M, Matsumoto M, Togashi H, Saito H (1995) Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav 51:515-519